F. Edmondson
Algemeen Adviseur bij ZAI LAB LIMITED
Vermogen: 488 605 $ op 31-05-2024
Profiel
F.
Ty Edmondson is currently the Secretary & Chief Legal Officer at Zai Lab Ltd.
Prior to this, he held the position of Secretary, Associate General Counsel & VP at Sumitomo Pharma America, Inc. and Chief Corporation Counsel & Senior Vice President at Biogen, Inc. from 2014 to 2020.
He completed his undergraduate degree at Washington & Lee University in 1988 and obtained his graduate degree from Widener University School of Law in 1993.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZAI LAB LTD.
0.03% | 14-05-2024 | 261 102 ( 0.03% ) | 488 605 $ | 31-05-2024 |
Actieve functies van F. Edmondson
| Bedrijven | Functie | Begin |
|---|---|---|
| ZAI LAB LIMITED | Algemeen Adviseur | 07-08-2020 |
Eerdere bekende functies van F. Edmondson
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-08-2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Bedrijfssecretaris | - |
Opleiding van F. Edmondson
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
